Aurelie Millier

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Cost-effectiveness of finerenone therapy for patients with chronic kidney disease and type 2 diabetes in England & Wales: results of the FINE-CKD model.

Cost-effectiveness of finerenone therapy for patients with chronic kidney disease and type 2 diabetes in England & Wales: results of the FINE-CKD model.

Journal: Journal of medical economics

Published: January 09, 2025

Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.

Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.

Journal: The British journal of psychiatry : the journal of mental science

Published: December 25, 2024

The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.

The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain.

Journal: PharmacoEconomics - open

Published: October 26, 2023

Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.

Validation of the FINE-CKD model for future health technology assessments for finerenone in patients with chronic kidney disease and type 2 diabetes.

Journal: The American journal of managed care

Published: August 23, 2022

Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.

Public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.

Journal: Journal of market access & health policy

Published: June 17, 2022

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease.

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease.

Journal: Journal of nephrology

Published: June 10, 2022

FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.

FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.

Journal: The American journal of managed care

Published: December 08, 2021

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands.

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands.

Journal: Journal of medical economics

Published: November 09, 2021

Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes.

Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes.

Journal: The American journal of managed care

Published: May 21, 2021

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.

Journal: PloS one

Published: November 19, 2020

Health economic evaluation of gene replacement therapies: methodological issues and recommendations.

Health economic evaluation of gene replacement therapies: methodological issues and recommendations.

Journal: Journal of market access & health policy

Published: November 04, 2020

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK.

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK.

Journal: Journal of market access & health policy

Published: September 18, 2020

Showing 1-12 of 72

Last Updated: 09/26/2026